Stock Trading Canary

United States · SEC Form 4 · Snapshot date: 2026-10-18 · Built: 2026-10-18 · 中文

← United States · Coverage record

US · SEC FORM 4

Nurix Therapeutics, Inc.

NRIX · Nasdaq · CIK 0001549595 · Healthcare · Biotechnology

INSIDER SIGNAL

No active buy signal

0 qualifying P purchase groups
in the current 180-day scoring window

56 Form 4 transaction lines observed in the same window
26 sales · 30 option, withholding, award, gift or other lines

Last qualifying purchaseNo qualifying purchase is present in the local Form 4 history.

WHY NO ACTIVE SIGNAL?

Purchase activityNone
Recent buyingNone
Recent salesHigh
Buy signal statusInactive
Score anatomy

No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.

ClusterNot calculated
Purchase sizeNot calculated
RoleNot calculated
RecencyNot calculated
ConvictionNot calculated

Why is there no score?

  • No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
  • Sales and other Form 4 activity remain visible as context and do not create a negative score.

Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.

Insider activity timeline

Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.

AprMayJunJulAugSepOct
Ring ChristineChief Legal Officer
○▼▼▼○▼○▼○▼○▼○▼○▼○▼
Hansen GwennChief Scientific Officer
○▼▼○▼▼○▼○▼○▼
van Houte HansChief Financial Officer
○▼▼○▼▼
GREGORY JULIA PDirector
○▼
● Purchase▼ Sale○ Other

—

Purchase breadth, concentration & cluster buying

These modules activate when qualifying purchases enter the 180-day research window.

SIGNAL HISTORY

No recorded active-signal snapshot

Scores are archived only when the company qualifies for a published US buy-signal snapshot.—

Recent Form 4 activity

0Purchases
43Sales
58Other Form 4 lines
36SEC filings · 365 days
BUYING0 qualifying P line(s) · 180 days
SELLING26 sale line(s) · context only
OTHER30 exercise / withholding / award / gift / other lines
10b5-1 / PLANNEDNot assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

Market context

Market context has not been captured for this ticker yet. The daily market-context job processes the US universe in rotating batches.

Short interest

Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.

Shares short
17,657,588
Previous report
17,976,804
Avg daily volume
1,776,243
Days to cover
9.9

FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.

Historical equity purchases

No qualifying code P equity purchase is present in the local Form 4 history.

Form 4 evidence

101 transaction lines in the latest 365-day window; 454 in local history.

DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-10-15Hansen GwennSale (S)Common Stock1,452USD 25.00USD 36,300SEC filing ↗
2026-10-15Hansen GwennOption exercise / conversion (M)Common Stock1,452USD 1.86USD 2,701SEC filing ↗
2026-10-14GREGORY JULIA PSale (S)Common Stock22,583USD 23.40USD 528,528SEC filing ↗
Show recent Form 4 evidence (30 grouped rows)
DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-10-15Hansen GwennSale (S)Common Stock1,452USD 25.00USD 36,300SEC filing ↗
2026-10-15Hansen GwennOption exercise / conversion (M)Common Stock1,452USD 1.86USD 2,701SEC filing ↗
2026-10-14GREGORY JULIA PSale (S)Common Stock22,583USD 23.40USD 528,528SEC filing ↗
2026-10-14GREGORY JULIA POption exercise / conversion (M)Common Stock22,583USD 1.86USD 42,004SEC filing ↗
2026-10-02Ring ChristineSale (S)Common Stock5,786USD 23.19USD 134,149SEC filing ↗
2026-10-02Ring ChristineOption exercise / conversion (M)Common Stock5,786USD 8.72USD 50,454SEC filing ↗
2026-09-02Ring ChristineSale (S)Common Stock5,787USD 25.76USD 149,048SEC filing ↗
2026-09-02Ring ChristineOption exercise / conversion (M)Common Stock5,787USD 8.72USD 50,463SEC filing ↗
2026-09-01Hansen GwennSale (S)Common Stock1,452USD 25.47USD 36,982SEC filing ↗
2026-09-01Hansen GwennOption exercise / conversion (M)Common Stock1,452USD 1.86USD 2,701SEC filing ↗
2026-08-05Hansen GwennSale (S)Common Stock4,356USD 25.00USD 108,900SEC filing ↗
2026-08-05Hansen GwennOption exercise / conversion (M)Common Stock4,356USD 1.86USD 8,102SEC filing ↗
2026-08-04Hansen GwennSale (S)Common Stock4,111USD 24.36USD 100,140SEC filing ↗
2026-08-04van Houte HansSale (S)Common Stock4,761USD 24.36USD 115,995SEC filing ↗
2026-08-03Ring ChristineSale (S)Common Stock16,589USD 23.05USD 382,376SEC filing ↗
2026-08-03Ring ChristineOption exercise / conversion (M)Common Stock5,787USD 8.72USD 50,463SEC filing ↗
2026-07-30van Houte HansSale (S)Common Stock2,845USD 23.38USD 66,516SEC filing ↗
2026-07-30van Houte HansOption exercise / conversion (M)Common Stock10,180USD 0.00USD 0SEC filing ↗
2026-07-30Ring ChristineSale (S)Common Stock3,847USD 23.38USD 89,943SEC filing ↗
2026-07-30Ring ChristineOption exercise / conversion (M)Common Stock10,180USD 0.00USD 0SEC filing ↗
2026-07-30Hansen GwennSale (S)Common Stock3,847USD 23.38USD 89,943SEC filing ↗
2026-07-30Hansen GwennOption exercise / conversion (M)Common Stock10,180USD 0.00USD 0SEC filing ↗
2026-07-02Ring ChristineSale (S)Common Stock11,008USD 23.56USD 259,348SEC filing ↗
2026-07-02Ring ChristineOption exercise / conversion (M)Common Stock11,008USD 5.47USD 60,174SEC filing ↗
2026-06-25Ring ChristineSale (S)Common Stock28,935USD 20.06USD 580,436SEC filing ↗
2026-06-25Ring ChristineOption exercise / conversion (M)Common Stock28,935USD 8.05USD 232,847SEC filing ↗
2026-06-25Hansen GwennSale (S)Common Stock5,394USD 20.00USD 107,880SEC filing ↗
2026-06-02Ring ChristineSale (S)Common Stock8,148USD 16.60USD 135,257SEC filing ↗
2026-06-02Ring ChristineOption exercise / conversion (M)Common Stock3,422USD 1.86USD 6,365SEC filing ↗
2026-05-05van Houte HansSale (S)Common Stock14,055USD 16.60USD 233,381SEC filing ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

Snapshot & identity

Snapshot date2026-10-18
Ranking versionUS-v1.2
Data qualityPASS ELIGIBLE · —
TickerNRIX
CIK0001549595
SectorHealthcare
IndustryBiotechnology Yahoo Finance
SEC SIC2834 Pharmaceutical Preparations
ExchangeNasdaq

Data coverage

Local Form 4 history454 transaction lines from 2020-07-28 to 2026-10-15
0 P purchase lines · 194 S sale lines · 260 other lines
SEC company submissionsOpen SEC filings ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.